EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Dimeric Peptide (KKYRYHLKPF)2K Shows Broad-Spectrum Antiviral Activity by Inhibiting Different Steps of Chikungunya and Zika Virus Infection

Gabriela Miranda Ayusso iD, Maria Letícia Duarte Lima iD, Paulo Ricardo da Silva Sanches, Igor Andrade Santos iD, Daniel Oliveira Silva Martins iD, Pâmela Jóyce Previdelli da Conceição, Tamara Carvalho, Vivaldo Gomes da Costa, Cíntia Bittar, Andres Merits iD, Norival Alves Santos-Filho iD, Eduardo Maffud Cilli iD und 3 weitere

Viruses · 2023

DOI: 10.3390/v15051168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Gabriela Miranda Ayusso und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil. Hauptthemen laut MEDLINE: Zika Virus Infection, Zika Virus, Chikungunya Fever, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKV) and Zika virus (ZIKV) are important disease-causing agents worldwide. Currently, there are no antiviral drugs or vaccines approved to treat these viruses. However, peptides have shown great potential for new drug development. A recent study described (p-BthTX-I)2K [(KKYRYHLKPF)2K], a peptide derived from the Bothropstoxin-I toxin in the venom of the Bothrops jararacussu snake, showed antiviral activity against SARS-CoV-2. In this study, we assessed the activity of this peptide against CHIKV and ZIKV and its antiviral action in the different stages of the viral replication cycle in vitro. We observed that (p-BthTX-I)2K impaired CHIKV infection by interfering with the early steps of the viral replication cycle, reducing CHIKV entry into BHK-21 cells specifically by reducing both the attachment and internalization steps. (p-BthTX-I)2K also inhibited the ZIKV replicative cycle in Vero cells. The peptide protected the cells against ZIKV infection and decreased the levels of the viral RNA and the NS3 protein of this virus at viral post-entry steps. In conclusion, this study highlights the potential of the (p-BthTX-I)2K peptide to be a novel broad-spectrum antiviral candidate that targets different steps of the replication cycle of both CHIKV and ZIKV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika Virus InfectionZika VirusChikungunya FeverCOVID-19Chikungunya virusVirusesAnimalsChlorocebus aethiopsHumansVero CellsAntiviral AgentsVirus ReplicationSARS-CoV-2Peptides

Stichwörter der Autor:innen

CHIKVZIKVantiviralpeptide

Substanzen

Antiviral AgentsPeptides

Autor:innen und Institutionen

  • Institute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.
  • School of Pharmaceutical Sciences, São Paulo State University, Araraquara 14800-903, SP, Brazil.
  • Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38408-100, MG, Brazil.
  • Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.
  • Institute of Technology, University of Tartu, 50090 Tartu, Estonia.
  • Institute of Chemistry, São Paulo State University, Araraquara 14800-060, SP, Brazil.

ORCID-Profile: Gabriela Miranda Ayusso, Maria Letícia Duarte Lima, Igor Andrade Santos, Daniel Oliveira Silva Martins, Andres Merits, Norival Alves Santos-Filho, Eduardo Maffud Cilli, Ana Carolina Gomes Jardim, Paula Rahal

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Zitieren

APA

Ayusso, G. M., Lima, M. L. D., da Silva Sanches, P. R., Santos, I. A., Martins, D. O. S., da Conceição, P. J. P., Carvalho, T., da Costa, V. G., Bittar, C., Merits, A., Santos-Filho, N. A., Cilli, E. M., Jardim, A. C. G., de Freitas Calmon, M., & Rahal, P. (2023). The Dimeric Peptide (KKYRYHLKPF)2K Shows Broad-Spectrum Antiviral Activity by Inhibiting Different Steps of Chikungunya and Zika Virus Infection. Viruses. https://doi.org/10.3390/v15051168

Vancouver

Ayusso GM, Lima MLD, da Silva Sanches PR, Santos IA, Martins DOS, da Conceição PJP, et al. The Dimeric Peptide (KKYRYHLKPF)2K Shows Broad-Spectrum Antiviral Activity by Inhibiting Different Steps of Chikungunya and Zika Virus Infection. Viruses. 2023. doi:10.3390/v15051168

BibTeX
@article{Ayusso2023,
  author = {Ayusso, Gabriela Miranda and Lima, Maria Letícia Duarte and da Silva Sanches, Paulo Ricardo and Santos, Igor Andrade and Martins, Daniel Oliveira Silva and da Conceição, Pâmela Jóyce Previdelli and Carvalho, Tamara and da Costa, Vivaldo Gomes and Bittar, Cíntia and Merits, Andres and Santos-Filho, Norival Alves and Cilli, Eduardo Maffud and Jardim, Ana Carolina Gomes and de Freitas Calmon, Marilia and Rahal, Paula},
  title = {The Dimeric Peptide (KKYRYHLKPF)2K Shows Broad-Spectrum Antiviral Activity by Inhibiting Different Steps of Chikungunya and Zika Virus Infection},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15051168}
}
Kostenlos starten →